UPDATED Apr 21, 2024
Companies with a Value score of at least 3, ordered by Value score
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
89W | €3.82 | 1.3% | -16.4% | €222.0m | €5.40 | PE20.2x | E41.9% | n/a | Utilities | ||
OCI | €7.25 | 0% | 27.3% | €10.0b | €6.96 | PE12.8x | E3.7% | 2.4% | Capital Goods | ||
5F9 | JP¥9.00 | -2.7% | 0% | JP¥27.2b | n/a | PB0.3x | n/a | 5.0% | Banks | ||
NWQ | HK$0.21 | 8.8% | 66.7% | HK$1.9b | n/a | PE5.5x | E24.3% | 9.0% | Consumer Durables | ||
HDK | UK£1.78 | 2.3% | -20.9% | UK£321.7m | UK£2.32 | PE9.5x | E11.4% | 6.8% | Retail | ||
UR9 | AU$8.74 | -4.0% | -29.1% | AU$720.5m | AU$15.20 | PE23.9x | E12.3% | 0.3% | Pharmaceuticals & Biotech | ||
GCC | UK£1.80 | -3.2% | 6.5% | UK£626.0m | UK£2.28 | PE26.7x | E25.4% | 2.0% | Food, Beverage & Tobacco | ||
SB7 | CA$17.36 | -2.6% | -26.9% | CA$10.9b | CA$21.36 | PE32.8x | E17.0% | 2.9% | Food, Beverage & Tobacco | ||
RB8 | US$146.00 | -3.9% | 25.9% | US$10.6b | US$178.34 | PS1.7x | E96.6% | 0.9% | Capital Goods | ||
0OO | CA$96.50 | -2.0% | 50.8% | CA$987.2m | CA$116.47 | PE11.3x | S4.5% | 2.8% | Food, Beverage & Tobacco | ||
SPXB | R$10.70 | -3.6% | 52.9% | R$78.9b | R$12.01 | PE5.6x | E-7.9% | 1.9% | Materials | ||
9VK | CA$0.59 | 0% | -35.7% | CA$61.9m | CA$1.62 | PS1.6x | E61.8% | n/a | Consumer Services | ||
PEKB | kr5.19 | 0.3% | 10.9% | kr17.8b | kr4.84 | PE8.9x | E-4.6% | 2.4% | Capital Goods | ||
CSF0 | €30.00 | -3.2% | 10.3% | €32.1b | €31.46 | PE33.8x | E15.1% | 2.2% | Capital Goods | ||
A35 | US$166.00 | -1.2% | 33.9% | US$1.9b | US$205.63 | PE11.5x | E5.3% | 3.1% | Diversified Financials | ||
H3L | HK$0.28 | -4.7% | -73.9% | HK$1.4b | n/a | PB0.7x | E125.4% | n/a | Healthcare | ||
PHS | kr4.68 | 0% | n/a | kr1.5b | kr7.34 | PE5563.3x | E88.3% | 0% | Pharmaceuticals & Biotech | ||
KHE | JP¥29.13 | -2.2% | 48.1% | JP¥803.8b | JP¥29.14 | PB1.4x | E40.2% | 0.8% | Capital Goods | ||
FE7 | US$34.80 | 0% | -5.5% | US$22.0b | US$37.41 | PE19.6x | E11.2% | 4.3% | Utilities | ||
079A | US$17.11 | -1.8% | 6.6% | US$3.3b | US$19.30 | PE13.2x | E20.9% | 13.4% | Diversified Financials | ||
1T3 | US$18.80 | -6.0% | -1.6% | US$1.8b | US$31.79 | PB3.2x | E20.5% | n/a | Pharmaceuticals & Biotech | ||
32P | UK£16.40 | -0.6% | 35.5% | UK£605.7m | UK£24.61 | PE27x | E28.6% | 2.8% | Consumer Services | ||
AMI | €0.80 | 37.9% | -32.8% | €12.1m | €3.30 | PS3.6x | E113.8% | n/a | Software | ||
PU8 | €11.00 | -4.3% | 37.5% | €4.0b | €16.68 | PE9.3x | E9.7% | 2.3% | Utilities |